LIOS and TBD Pharmatech join forces
LIOS and TBD Pharmatech join forces
On 21st February 2023, the Latvian Institute of Organic Synthesis (LIOS) and TBD Pharmatech signed the Memorandum of Understanding to strengthen the drug manufacturing performance of the Baltic region. The alliance will perform joint projects for manufacturing technology development and the production of active pharmaceutical ingredients (APIs). It will also support and promote new trends in API manufacturing such as the introduction of green technologies and advanced safety aspects. “Memorandum of understanding with TBD Pharmatech is a very important step forward for LIOS to become an integral part of the API technologies development ecosystem by linking our research capacities to
Pharmaceutical compliance
Pharmaceutical compliance is a crucial part of the drug development process. It includes the processes and activities undertaken by a pharmaceutical company to ensure that its products meet all the applicable regulatory requirements. What is pharmaceutical compliance? Pharmaceutical compliance refers to the process of ensuring that a product or service meets all applicable regulations before it can be released to patients. This includes everything from making sure that the ingredients are properly sourced to ensuring that manufacturing processes meet stringent quality control standards. Compliance also applies to marketing materials, labeling requirements, and advertising regulations. Companies must ensure that their products
Maarjavälja career day 2023
On 9th of February the annual Maarjavälja career day 2023 took place. The career day is organized by Faculty of Science and Technology of University of Tartu. The event brings together companies and students from fields of chemistry, physics, genomics, molecular and cell biology etc. Hence, for students this is a perfect opportunity to meet their future internship and career possibilities. TBD Pharmatech participated in the career day to introduce the opportunities for students specializing in chemistry. As a one of a kind company in Estonia developing and producing API-s working at TBD Pharmatech is an unique option to start
Medicine shortage: actions taken in Estonia and EU
Lately the shortage of medicines and health products has become an important topic everywhere around the world. Health professionals from European countries, as well as from Canada and US have been warning about potential medicine shortage. In the end of December such effect were clear in Estonia too when antipyretic syrups were nowhere to be found. At the same time doctors needed to find alternative treatments for patients in need for some specific antibiotics since they were also short in supply. Causes of shortages The supply chain disruption in pharmaceuticals is actually nothing unprecedented. However, the past few years have
CMC in pharma
Chemistry, Manufacturing and Controls (CMC) is a critical component of the drug development process. CMC in pharma is responsible for ensuring that the drugs being developed are safe, effective and high-quality. What is CMC? CMC stands for Chemistry, Manufacturing and Controls. It’s a term used in pharma to refer to various procedures involved in developing, producing and testing pharmaceutical products. CMC also includes processes such as identification of raw materials used in production, establishing standards of quality control and specifications for finished products. Furthermore, product stability testing, verifying manufacturing methods and equipment used in production. The main purpose of CMC
Change of legal name – officially TBD Pharmatech
On Friday, 13th of January 2023 the legal name of our company was changed to osaühing TBD Pharmatech. We started using the new name already in September 2022 as it was a big part of the whole rebranding process. Now we can fairly say that the rebranding is complete and TBD-Biodiscovery has officially become TBD Pharmatech. Here‘s an article in Meditsiiniuudised about the rebranding of TBD.
GMP for APIs
Good Manufacturing Practice (GMP) is a set on important requirements of the drug manufacturing process. It is a system for ensuring that active pharmaceutical ingredients (APIs) are produced safely, consistently and in compliance with relevant regulatory standards. What is GMP? GMP stands for Good Manufacturing Practice and refers to a set of guidelines that must be followed when manufacturing APIs. These guidelines are designed to ensure that the production process meets a certain level of quality control, safety and consistency. They have been developed by regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines
What is an Active Pharmaceutical Ingredient (API) in pharma?
Active Pharmaceutical Ingredient, or API, is the chemical or compound found in drugs and medications that produce their intended therapeutic effects. They are the main active ingredients of a drug and typically make up between 40-90% of the total mass of a pill or capsule. What is an Active Pharmaceutical Ingredient? An Active Pharmaceutical Ingredient (API) is the component in a drug that produces its effects. This can be either a chemical compound or a combination of compounds. An API may be composed of one single compound or multiple compounds working together to produce the desired effect. For example, aspirin
Chemistry students getting to know career opportunities
On 28th of November TÜKS aka Tartu Ülikooli Keemiaüliõpilaste Selts (University of Tartu Chemistry Students’ Association) paid a visit to TBD Pharmatech. Students were interested in getting acquainted to TBD’s everyday work and therefore getting a better look at chemist’s career opportunities. The visit started with an introduction to TBD. Our chemist-project manager Jürgen Vahter introduced the history, field of activity, projects and the company in general to the students. The presentation was followed by a tour in quality control laboratory with head of QC Yauheni Yulin. The last stop was at our largest production room together with head of manufacturing Ivan Ogibalov.
Ravimikonverents 2022
On 18th of November the annual medicine conference Ravimikonverents 2022 took place. Conference organized by Äripäev and Meditsiiniuudised brings together all important links of Estonian medicinal industry. TBD Pharmatech’s CEO Andrus Tasa participated in discussion group held within the conference. Together with other Estonian pharmaceutical companies the challenges of Estonian own medicinal industry were discussed. Read more about the conference here: https://pood.aripaev.ee/ravimikonverents2022#top